medigraphic.com
ISSN 1561-3011 (Electronic)

2021, Number 3

<< Back Next >>

Rev Cubana Invest Bioméd 2021; 40 (3)

Characterization of patients with major salivary gland neoplasms treated surgically in a Cuban university hospital

Cubas-Escobar D, Corrales-Reyes IE

Language: Spanish
References: 33
Page: 1-12
PDF size: 264.63 Kb.


ABSTRACT

Introduction: Salivary gland neoplasms are the most heterogeneous and complex group of head and neck tumoral processes.
Objective: Characterize patients with major salivary gland neoplasms undergoing surgical treatment in a Cuban university hospital.
Methods: A cross-sectional observational descriptive study was conducted of patients histologically diagnosed with major salivary gland neoplasms. The variables evaluated were age, sex, type of neoplasm, primary site, histological diagnosis and surgical techniques.
Results: A total 55 neoplasms were studied, of which 45 (81.82%) were benign, with a higher frequency in men (n = 28; 62.22%). Mean age at neoplasm presentation was 55.11 ± 16.04 years, and the most affected age group was 40-59 years (n = 26; 47.27%). The parotid was the most frequently affected gland (n = 48), mainly by pleomorphic adenomas (n = 28; 58.33%). Subtotal parotidectomy was the most common surgical procedure (n = 38; 79.17%).
Conclusions: Benign parotid gland neoplasms presenting in male adult patients were the most frequent type.


REFERENCES

  1. Campolo A, Ramírez H, Vargas A, León A, Goñi I, Solar A. Epithelial tumors of salivary glands. Review of 286 pathology reports. Rev Med Chil. 2018;146:1159-66. PMID: 30724979

  2. Cunha JLS, Coimbra ACP, Silva JVR, Nascimento ISd, Andrade MEd, Oliveira CRd, et al. Epidemiologic analysis of salivary gland tumors over a 10-years period diagnosed in a northeast Brazilian population. Med Oral Patol Oral Cir Bucal. 2020;25(4):e516-22. DOI: 10.4317/medoral.23532

  3. Hernando M, Martín-Fragueiro L, Eisenberg G, Echarria R, García-Peces V, Urbasos M. Tratamiento quirúrgico de los tumores de glándulas salivales. Acta Otorrinolaringol Esp. 2009;60(5):340-5. DOI: 10.1016/j.otorri.2009.04.001

  4. Noel L, Medford S, Islam S, Muddeen A, Greaves W, Juman S. Epidemiology of salivary gland tumours in an Eastern Caribbean nation: A retrospective study. Ann Med Surg (Lond). 2018;8:148-51. DOI: 10.1016/j.amsu.2018.10.039

  5. Vasconcelos AC, Nör F, Meurer L, Salvadori G, Souza LB, Vargas PA, et al. Clinicopathological analysis of salivary gland tumors over a 15-year period. Braz Oral. 2016;30:e2. DOI: 10.1590/1807-3107BOR-2016.vol30.0002

  6. da Silva LP, Serpa MS, Viveiros SK, Sena DAC, de Carvalho Pinho RF, de Abreu Guimarães LD, et al. Salivary gland tumors in a Brazilian population: A 20-year retrospective and multicentric study of 2292 cases. J Craniomaxillofac Surg. 2018;46:2227-33. DOI: 10.1016/j.jcms.2018.09.028

  7. Fomete B, Adebayo ET, Ononiwu CN. Management of salivary gland tumors in a Nigerian tertiary institution. Ann Afr Med. 2015;14:148-54. DOI: 10.4103/1596-3519.152071

  8. Taghavi N, Sargolzaei S, Mashhadiabbas F, Akbarzadeh A, Kardouni P. Salivary Gland Tumors: A 15- year Report from Iran. Turk Patoloji Derg. 2016 [acceso: 24/08/2020]; 32:35-9. Disponible en: https://content.sciendo.com/downloadpdf/journals/tjop/32/1/article-p35.xml

  9. Araya J, Martinez R, Niklander S, Marshall M, Esguep A. Incidence and prevalence of salivary gland tumours in Valparaiso, Chile. Med Oral Patol Oral Cir Bucal. 2015;20:e532-9. PMCID: PMC4598920

  10. Mahmoud M, Magatón A, Pinto M, González H, Magatón D. Incidencia de tumor de glándula parótida. Rev Venez Oncol. 2013 [acceso: 24/08/2020]; 25(2):109-12. Disponible en: http://www.redalyc.org/articulo.oa?id=375634876002

  11. Boza-Mejías Y, Romero-Rodríguez J, Pérez-Abreus E, López-Fernández R, Duménico-Soler A, Barrios T. Tumores de las glándulas salivales mayores. Estudio de una serie de casos. Rev Finlay. 2012 [acceso: 24/08/2020]; 2(3):159-66. Disponible en. http://www.revfinlay.sld.cu/index.php/finlay/article/view/124

  12. Rodríguez R, Coca RM, Jiménez Y. Afecciones quirúrgicas de las glándulas salivales mayores. Algoritmo diagnóstico-terapéutico. Acta Méd Centro. 2014 [acceso: 24/08/2020]; 8(4):74-9. Disponible en: http://www.revactamedicacentro.sld.cu/index.php/amc/article/view/182/292

  13. Expósito DG, Wilcarani M, Pérez ML, Valdés Y, Expósito ÁD. Comportamiento de los tumores de glándulas salivales en el Hospital Docente Vladimir Ilich Lenin. CCM. 2017 [acceso: 24/08/2020]; (2):511-25. Disponible en: http://scielo.sld.cu/pdf/ccm/v21n2/ccm16217.pdf

  14. Bittar RF, Ferraro HP, Moraes Gonçalves FT, Couto da Cunha MG, Biamino ER. Neoplasms of the salivary glands: analysis of 727 histopathological reports in a single institution. Otolaryngol Pol. 2015;69:28-33. DOI: 10.5604/00306657.1163578

  15. Upton DC, Mcnamar JP, Connor NP, Hanari PM, Hartig GK. Parotidectomy: ten-years review of 237 cases at a single institution. Otolaryngol Head Neck Surg. 2013;136:788-92. DOI: 10.1016/j.otohns.2006.11.037

  16. Gilbert MR, Sharma A, Schmitt NC, Johnson JT, Ferris RL, Duvvuri U, et al. A 20-Year Review of 75 Cases of Salivary Duct Carcinoma. Otolaryngol Head Neck Surg. 2016;142(5):489-95. DOI: 10.1001/jamaoto.2015.3930

  17. Guangyan Y, Peng X. Conservative and functional surgery in the treatment of salivary gland tumours. Int J Oral Sci. 2019;11:22. DOI: 10.1038/s41368-019-0059-9

  18. Luksic I, Mamic M, Suton P. Management of accessory parotid gland tumours: 32-year experience from a single institution and review of the literature. Int J Oral Maxillofac Surg. 2019;48:1145-52. DOI: 10.1016/j.ijom.2019.02.014

  19. Stodulski D, Mikaszewski B, Majewska H, Kuczkowski J. Parotid salivary duct carcinoma: a single institution's 20-year experience. Europ Arch of Oto-Rhino-Laryngol. 2019;276:2031-38. DOI: 10.1007/s00405-019-05454-0

  20. Croonenborghs TM, Van Hevele J, Scheerlinck J, Nout E, Schoenaers J, Politis C. A multicentre retrospective clinico-histopathological review of 250 patients after parotidectomy. Int J Oral Maxillofac Surg. 2020,49(2):149-56. DOI: 10.1016/j.ijom.2019.03.963

  21. Tian Z, Li L, Wang L, Hu Y, Li J. Salivary gland neoplasms in oral and maxillofacial regions: a 23-year retrospective study of 6,982 cases in an Eastern Chinese population. Int J Oral Maxillofac Urg. 2010;39:235-42. DOI: 10.1016/j.ijom.2009.10.016

  22. Lukšić I, Virag M, Manojlović S, Macan D. Salivary gland tumours: 25 year of experience a single institution in Croatia. J Craniomaxillofac Surg. 2012;40:e75-e81. DOI: 10.1016/j.jcms.2011.05.002

  23. Fonseca PF, de Vasconcelos CM, Paes de AO, Ayroza Rangel ALC, Hirata TAM, Galvão BA. Clinicopathologic analysis of 493 cases of salivary gland tumors in a Southern Brazilian population. Oral Surg Oral Med Oral Pathol Oral Radiol. 2012;114(2):230-239. DOI: 10.1016/j.oooo.2012.04.008

  24. Sánchez RE, Pérez GP, Sánchez PE, Castro TM, Correa RE. Parotidectomía. Experiencia de 1992-2013. Rev Inf Cient. 2018 [acceso: 24/08/2020]; 97(1). Disponible en: http://www.revinfcientifica.sld.cu/index.php/ric/article/view/1813

  25. Wang XD, Meng LJ, Hou TT, Huang SH. Tumours of the salivary glands in northeastern China: a retrospective study of 2508 patients. Br J Oral Maxillofac Surg. 2015;53:132-7. DOI: 10.1016/j.bjoms.2014.10.008

  26. Gao M, Hao Y, Huang MX, Ma DQ, Chen Y, Luo HY, et al. Salivary gland tumours in a northern Chinese population: a 50-year retrospective study of 7190 cases. Int J Oral Maxillofac Surg. 2017;46:343-49. DOI: 10.1016/j.ijom.2016.09.021

  27. Arribas I, Martínez F, García A, Álvarez M. Reconstrucción de defectos parotídeos con injertos de tejido graso libre abdominal. Estudio clínico de una sencilla técnica quirúrgica. Rev Esp Cir Oral Maxilofac. 2020;42(1):4-11. DOI: 10.20986/recom.2020.1101/2019

  28. Bradley PJ. Frequency and Histopathology by Site, Major Pathologies, Symptoms and Signs of Salivary Gland Neoplasms. Adv Otorhinolaryngol. 2016;78:9-16. DOI: 10.1159/000442120

  29. Sagiv D, Witt RL, Glikson E, Mansour J, Shalmon B, Yakirevitch A, et al. Warthin tumor within the superficial lobe of the parotid gland: a suggested criterion for diagnosis. Eur Arch Otorhinolaryngol. 2017 [acceso: 24/08/2020]; 274(4):1993-6. Disponible en: http://link.springer.com/article/10.1007/s00405-016-4436-0

  30. Lombardi D, McGurk M, Vander Poorten V, Guzzo M, Accorona R, Rampinelli V, et al. Surgical treatment of salivary malignant tumors. Oral Oncol. 2017 [acceso: 24/08/2020]; 65:102-13. Disponible en: http://www.sciencedirect.com/science/article/pii/S1368837516302421

  31. Maza S, Sánchez G, Herrero S, Benavente B, Ventura D, Mingo F. Clasificación pronóstica de los tumores malignos de glándula parótida. Rev Esp Cir Oral Maxilofac 2016 [acceso: 24/08/2020]; 38(1). Disponible en: http://scielo.isciii.es/pdf/maxi/v38n1/original2.pdf

  32. Campolo GA, Ramirez SH, Vargas DA, León RA, Goñi EI. Perfil epidemiológico de neoplasias epiteliales de glándulas salivales. Rev Med Chile. 2018;146:1159-66. DOI: 10.4067/S0034-98872018001001159

  33. Sotelo JJ, Pérez MM, Alderete VG, Capetillo HG, Grube PP. Tumores de glándulas salivales en Veracruz. Experiencia de dos instituciones. Rev Med Inst Mex Seguro Soc. 2018 [acceso: 24/08/2020]; 56(2):154-7. Disponible en: https://www.redalyc.org/jatsRepo/4577/457754717009/457754717009.pdf




2020     |     www.medigraphic.com